Cargando…
Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects
Glioblastoma is the most frequent and malignant type of brain tumor. It has a reputation for being resistant to current treatments, and the prognosis is still bleak. Immunotherapies have transformed the treatment of a variety of cancers, and they provide great hope for glioblastoma, although they ha...
Autores principales: | Chowdhury, Selia, Bappy, Mehedi Hasan, Clocchiatti-Tuozzo, Santiago, Cheeti, Srinidhi, Chowdhury, Samia, Patel, Vraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782638/ https://www.ncbi.nlm.nih.gov/pubmed/35103180 http://dx.doi.org/10.7759/cureus.20604 |
Ejemplares similares
-
COVID-19 and Pregnancy
por: Chowdhury, Selia, et al.
Publicado: (2022) -
CD133 Expression in Glioblastoma Multiforme: A Literature Review
por: Ahmed, Syed Ijlal, et al.
Publicado: (2018) -
Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population
por: Grech, Neil, et al.
Publicado: (2020) -
Risk of Glioblastoma Multiforme in Patients Taking Ion Channel Blockers
por: Hallan, David R, et al.
Publicado: (2022) -
Glioblastoma Multiforme in a Patient With Alpha-1-Antitrypsin Deficiency
por: Ober, Curtis, et al.
Publicado: (2023)